Skip to Main Content

Author Details

Chandra Sekhar Pedamallu
Broad Institute
2009
58
38
PMIDPaper TitleJournal TitlePublished Year
36697831Author Correction: Genomic basis for RNA alterations in cancer.Nature2023
36697831Author Correction: Genomic basis for RNA alterations in cancer.Nature2023
34203201Dissection of <i>PIK3CA</i> Aberration for Cervical Adenocarcinoma Outcomes.Cancers (Basel)2021
33530869Characterization of Plasmacytoid Dendritic Cells, Microbial Sequences, and Identification of a Candidate Public T-Cell Clone in Kikuchi-Fujimoto Disease.Pediatr Dev Pathol2021
34203201Dissection of <i>PIK3CA</i> Aberration for Cervical Adenocarcinoma Outcomes.Cancers (Basel)2021
34572780Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas.Cancers (Basel)2021
34620846Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.NPJ Genom Med2021
33530869Characterization of Plasmacytoid Dendritic Cells, Microbial Sequences, and Identification of a Candidate Public T-Cell Clone in Kikuchi-Fujimoto Disease.Pediatr Dev Pathol2021
34572780Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas.Cancers (Basel)2021
34620846Genomic alterations associated with mutational signatures, DNA damage repair and chromatin remodeling pathways in cervical carcinoma.NPJ Genom Med2021
32539694Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence.BMC Cancer2020
32539694Targeting the oncogene LSF with either the small molecule inhibitor FQI1 or siRNA causes mitotic delays with unaligned chromosomes, resulting in cell death or senescence.BMC Cancer2020
30564890Identification and characterization of an alternative cancer-derived PD-L1 splice variant.Cancer Immunol Immunother2019
30564890Identification and characterization of an alternative cancer-derived PD-L1 splice variant.Cancer Immunol Immunother2019
31433971The Immune Landscape of Cancer.Immunity2019
31433971The Immune Landscape of Cancer.Immunity2019
29622466Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.Cancer Cell2018
29982281GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts.Bioinformatics2018
30096301Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2018
29955181Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29955182Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29955178Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer.Nat Genet2018
29622466Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.Cancer Cell2018
29713087Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
30096301Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2018
29982281GATK PathSeq: a customizable computational tool for the discovery and identification of microbial sequences in libraries from eukaryotic hosts.Bioinformatics2018
29955181Publisher Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29955182Author Correction: Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
29955178Genome-scale analysis identifies paralog lethality as a vulnerability of chromosome 1p loss in cancer.Nat Genet2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
29713087Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.Nat Med2018
28658632Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
28988769Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2017
28658632Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
28514651Modeling Genomic Instability and Selection Pressure in a Mouse Model of Melanoma.Cell Rep2017
29170280Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer.Science2017
28297679Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
28297679Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles.Cell Rep2017
28988769Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2017
29170280Analysis of <i>Fusobacterium</i> persistence and antibiotic response in colorectal cancer.Science2017
28514651Modeling Genomic Instability and Selection Pressure in a Mouse Model of Melanoma.Cell Rep2017
26095338Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas.Gastric Cancer2016
27158780Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.Nat Genet2016
26095338Validation and calibration of next-generation sequencing to identify Epstein-Barr virus-positive gastric cancer in The Cancer Genome Atlas.Gastric Cancer2016
27801610Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.Cancer Biol Ther2016
28174737Metagenomic Characterization of Microbial Communities <i>In Situ</i> Within the Deeper Layers of the Ileum in Crohn's Disease.Cell Mol Gastroenterol Hepatol2016
28174737Metagenomic Characterization of Microbial Communities <i>In Situ</i> Within the Deeper Layers of the Ileum in Crohn's Disease.Cell Mol Gastroenterol Hepatol2016
27801610Kmt2a cooperates with menin to suppress tumorigenesis in mouse pancreatic islets.Cancer Biol Ther2016
27158780Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.Nat Genet2016
  • 1 - 50 of 116

Recommended Authors

The Hospital for Sick Children
Career Start Year 2012
Number of shared co-authors 7
Weizmann Institute of Science
Career Start Year 2012
Number of shared co-authors 6
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 2
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 2010
Number of shared co-authors 7
Universitat de Barcelona (UB)
Career Start Year 2010
Number of shared co-authors 10
Peter MacCallum Cancer Centre
Career Start Year 2007
Number of shared co-authors 2
UPMC Hillman Cancer Center
Career Start Year 2007
Number of shared co-authors 5
The National Institutes of Health
Career Start Year 2006
Number of shared co-authors 7
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 8
Manchester Cancer Research Centre, University of Manchester
Career Start Year 2006
Number of shared co-authors 21
Department of Immunology Erasmus University Medical Center
Career Start Year 2006
Number of shared co-authors 3
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 4
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 2
University of Augsburg
Career Start Year 2004
Number of shared co-authors 19
McDonnell Genome Institute, Washington University in St. Louis School of Medicine
Career Start Year 2004
Number of shared co-authors 3
Icahn School of Medicine at Mount Sinai
Career Start Year 2004
Number of shared co-authors 6
Washington University
Career Start Year 2003
Number of shared co-authors 22
University of California
Career Start Year 2003
Number of shared co-authors 5
The Francis Crick Institute
Career Start Year 2003
Number of shared co-authors 15
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 46
Spanish National Cancer Research Centre-CNIO
Career Start Year 2002
Number of shared co-authors 1
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 8
HudsonAlpha Institute for Biotechnology
Career Start Year 1999
Number of shared co-authors 7
National Human Genome Research Institute, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 8
Human Phenome Institute and Shanghai Cancer Center, Fudan University
Career Start Year 1997
Number of shared co-authors 7
The Ohio State University
Career Start Year 1997
Number of shared co-authors 9
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 76
Hospital Sirio-Libanes
Career Start Year 1994
Number of shared co-authors 1
The Ohio State University
Career Start Year 1988
Number of shared co-authors 50

Collaborators

Broad Institute
Co-authored papers 37
University of Alabama at Birmingham
Co-authored papers 21
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 18
Co-authored papers 15
Dana-Farber Cancer Institute
Co-authored papers 12
Broad Institute of MIT and Harvard
Co-authored papers 11
Fred Hutchinson Cancer Center
Co-authored papers 9
Co-authored papers 9
Co-authored papers 8
Broad Institute of MIT and Harvard
Co-authored papers 7
Stanford University
Co-authored papers 7
The University of Texas MD Anderson Cancer Center
Co-authored papers 7
St Vincent's Hospital Melbourne
Co-authored papers 7
Co-authored papers 7
Co-authored papers 6
Broad Institute of MIT and Harvard
Co-authored papers 6
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 6
Van Andel Institute
Co-authored papers 6
Co-authored papers 6
Broad Institute of MIT and Harvard
Co-authored papers 6
Co-authored papers 6
Cystic Fibrosis Foundation
Co-authored papers 6
Novartis Institutes for BioMedical Research
Co-authored papers 6
Present address: Dxige Research Inc.
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Broad Institute of MIT and Harvard
Co-authored papers 5